In a reversal, the FDA is reconsidering its decision to end the shortage status of tirzepatide, after a recent lawsuit and intense public pressure, The Washington Post reported Oct. 21.

Eli Lilly sues vendors for selling unauthorized tirzepatide amid resolved shortages. Lawsuits target vendors offering ...

The pill version of Novo Nordisk’s (NVO) blockbuster drug Ozempic was found to cut the risk of heart attacks, strokes, and ...

Eli Lilly said on Monday it sued three medical spas and online vendors for selling products claiming to contain tirzepatide, ...

Eli Lilly sued three medical spas and online vendors for selling products that claim to contain the ingredient in its ...

A recent study found significant reductions in opioid overdose and alcohol misuse among people taking GLP-1 drugs like ...

Here's all you need to know about Ozempic that Karan Johar is said to have used for fast weight loss. What are the benefits ...

MangoRx remains committed to its mission and plans to continue to enhance patient care by offering new and innovative ...

You've probably heard about the dramatic weight loss that can happen when you take Ozempic or Wegovy. These medications mimic ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 568.82% and ...

The Washington Post reports that intense public backlash and a lawsuit led the FDA to reconsider its declaration, made two weeks ago, that the shortage of weight-loss drugs Mounjaro and Zepbound is ...

The lawsuit singles out Pivotal Peptides, MangoRx and Genesis Lifestyle Medicine for either offering research-grade meds ...